PubAg

Main content area

Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease

Author:
Fang, Chongye, Cai, Xianbin, Hayashi, Shuhei, Hao, Shumei, Sakiyama, Haruhiko, Wang, Xuanjun, Yang, Qin, Akira, Shizuo, Nishiguchi, Shuhei, Fujiwara, Noriko, Tsutsui, Hiroko, Sheng, Jun
Source:
Biochimica et biophysica acta 2019 v.1864 no.3 pp. 271-280
ISSN:
1388-1981
Subject:
adipocytes, caffeine, fatty liver, hepatocytes, hepatoprotective effect, interleukin-6, knockout mutants, liver, macrophages, messenger RNA, mice, muscles, myotubes, oxygen consumption, risk reduction
Abstract:
Caffeine intake is associated with a reduced risk developing non-alcoholic fatty liver disease (NAFLD), but the underlying molecular mechanisms remain to be fully elucidated. We report here that caffeine markedly improved high fat diet-induced NAFLD in mice resulting in a 10-fold increase in circulating IL-6 levels, leading to STAT3 activation in the liver. Interestingly, the expression of IL-6 mRNA was not increased in the liver, but increased substantially in the muscles of caffeine-treated mice. Caffeine was found to stimulate IL-6 production in cultured myotubes but not in hepatocytes, adipocytes, or macrophages. The inhibition of p38/MAPK abrogated caffeine-induced IL-6 production in muscle cells. Caffeine failed to improve NAFLD in IL-6 and hepatocyte-specific STAT3 knockout mice, indicating that the IL-6/STAT3 pathway is vital for the hepatoprotective effects of caffeine in NAFLD. The possibility that IL-6/STAT3-mediated hepatic autophagosome induction and hepatocytic oxygen consumption are involved in the anti-NAFLD effects of caffeine cannot be excluded, based on the findings presented here. Our results reveal that caffeine ameliorates NAFLD via crosstalk between muscle IL-6 production and liver STAT3 activation.
Agid:
6258696